相关实验视频
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
细菌基因毒素的组合和功能
Dragana Nesić1, Yun Hsu, C Erec Stebbins
1Laboratory of Structural Microbiology, The Rockefeller University, New York 10021, USA.
Nature
|May 28, 2004
概括
细胞张毒素 (CDT) 的全毒素结构揭示了它的基因毒性机制. 它的DNase-I酶和酸盐类莱克丁域,以及特定的相互作用,对于DNA损伤和宿主细胞毒性至关重要.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 毒理学 毒理学 毒理学
背景情况:
- 细胞致死性扩张毒素 (CDT) 是一种三方毒素,会导致细胞循环停止和细胞亡.
- CDT的核酶子单元CdtB转移到宿主细胞中以诱导DNA损伤.
研究的目的:
- 为了阐明海莫菲勒斯·杜克雷伊 (Haemophilus ducreyi) CDT全毒素的晶体结构.
- 确定对CDT的基因毒性活性和宿主细胞相互作用至关重要的结构特征.
主要方法:
- 进行X射线晶体学以确定全毒素结构.
- 生物化学测试以评估DNA结合和基因毒性.
主要成果:
- 整体毒素包括DNase-I家族酶 (CdtB) 和两个类似于脂的莱克域 (CdtA,CdtC).
- 复杂的形成涉及相互依存的球状和非球状接口.
- 莱克子单元和CdtC的硬质块上的芳香表面对毒性至关重要.
- 在CdtB中确定了基因毒性必不可少的假定DNA结合残留物.
结论:
- 确定的结构为CDT的基因毒性机制提供了分子基础.
- 结构洞察力突出了对毒素活性负责的关键相互作用和领域.
- 这项工作有助于了解细菌毒素的功能和潜在的治疗策略.
相关概念视频
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K